Diagnostics And Consultation Center Convex Ltd.

The medical center is at the forefront of research into Sjögren’s Syndrome, focusing on innovative treatments to alleviate systemic manifestations and improve patient-reported symptoms in those with moderate-to-severe disease activity.

• Systemic Manifestations
• Patient-Reported Symptoms

Through cutting-edge clinical trials, the center is pioneering new therapeutic approaches that aim to enhance the quality of life for patients suffering from this complex autoimmune disorder.

Specializing in Chronic Inflammatory Demyelinating Polyneuropathy, the center is dedicated to assessing the long-term safety and efficacy of novel subcutaneous formulations, offering hope for improved management of this peripheral nerve disorder.

• Long-term Safety
• Subcutaneous Formulations

By advancing research in this area, the center contributes significantly to the development of therapies that enhance patient outcomes and quality of life.

The center is a leader in the study of Lupus Nephritis, particularly focusing on active proliferative forms. Research efforts are directed towards evaluating the efficacy of new treatments in achieving complete renal response.

• Complete Renal Response
• Proliferative Forms

These efforts are crucial in developing effective therapies that can significantly improve renal outcomes for patients with this challenging condition.

Focusing on Inflammatory Bowel Disease, including Crohn’s Disease and Ulcerative Colitis, the center is engaged in trials to assess the efficacy of new treatments in inducing clinical remission and endoscopic response.

• Clinical Remission
• Endoscopic Response

These studies are pivotal in advancing therapeutic options that aim to improve the management and quality of life for patients with these chronic conditions.

With a strong focus on Systemic Lupus Erythematosus, the center is involved in evaluating long-term safety and efficacy of novel treatments, aiming to reduce disease activity and improve patient outcomes.

• Long-term Safety
• Disease Activity Reduction

These research initiatives are essential in developing therapies that offer sustained relief and improved quality of life for patients.

The center is advancing research in Severe Asthma, focusing on the efficacy of new treatments in reducing asthma exacerbations, thereby offering potential improvements in disease management.

• Asthma Exacerbations
• Disease Management

Through these studies, the center aims to provide innovative solutions that enhance the quality of life for individuals with severe asthma.

Specializing in Multiple Sclerosis, the center is conducting research to assess the impact of new treatments on serum neurofilament levels, a key biomarker in disease progression.

• Serum Neurofilament Levels
• Disease Progression

This research is vital in developing therapies that can potentially slow disease progression and improve patient outcomes.

The center is at the cutting edge of research into Resistant Hypertension, focusing on the efficacy of new treatments in reducing ambulatory blood pressure in patients with this challenging condition.

• Ambulatory Blood Pressure
• Hypertension Management

These studies are crucial in developing effective therapies that can help manage blood pressure in patients who do not respond to conventional treatments.

Focusing on Hereditary Angioedema, the center is involved in trials to evaluate the safety and efficacy of new prophylactic treatments, aiming to reduce the frequency and severity of angioedema attacks.

• Prophylactic Treatments
• Angioedema Attacks

These efforts are essential in providing patients with more effective management options for this rare genetic disorder.

The center is pioneering research in Heart Failure with reduced ejection fraction, focusing on the efficacy and safety of new treatments to improve cardiac function and patient quality of life.

• Cardiac Function
• Quality of Life

These studies are critical in advancing therapeutic options that can significantly enhance the management of heart failure.

Specializing in Chronic Spontaneous Urticaria, the center is engaged in trials to evaluate the efficacy of new treatments in reducing urticaria activity, offering hope for improved management of this condition.

• Urticaria Activity
• Condition Management

These research efforts are vital in developing therapies that can provide relief and improve the quality of life for patients with chronic urticaria.

The center is advancing research in Migraine prevention, focusing on the efficacy of new treatments for patients who have not responded to prior preventative therapies.

• Preventative Therapies
• Migraine Management

These studies are crucial in providing new options for patients seeking effective migraine prevention strategies.